Evidence map›Paper›PMID 42317675›Full record

ArticleChemical science2026

Distinct adsorption behavior and structures of cell-penetrating peptides at a model lipid membrane interface: a heterodyne-detected vibrational sum frequency generation spectroscopy study.

Subhadip Roy, Mohammed Ahmed, Aniruddha Adhikari, Erika Kinoshita, Satoshi Nihonyanagi, Tahei Tahara

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Subhadip RoyMolecular Spectroscopy Laboratory, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan nsatoshi@riken.jp tahei@riken.jp.ORCID https://orcid.org/0000-0001-6649-5454
Mohammed AhmedMolecular Spectroscopy Laboratory, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan nsatoshi@riken.jp tahei@riken.jp.ORCID https://orcid.org/0000-0002-9347-1199
Aniruddha AdhikariMolecular Spectroscopy Laboratory, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan nsatoshi@riken.jp tahei@riken.jp.ORCID https://orcid.org/0000-0003-1189-9755
Erika KinoshitaMolecular Spectroscopy Laboratory, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan nsatoshi@riken.jp tahei@riken.jp.ORCID https://orcid.org/0009-0004-3147-234X
Satoshi NihonyanagiMolecular Spectroscopy Laboratory, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan nsatoshi@riken.jp tahei@riken.jp.ORCID https://orcid.org/0000-0003-0014-7427
Tahei TaharaMolecular Spectroscopy Laboratory, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan nsatoshi@riken.jp tahei@riken.jp.ORCID https://orcid.org/0000-0002-6340-8535

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arginine-rich cell-penetrating peptides (CPPs) are widely used as molecular delivery vectors, yet the molecular mechanism of their membrane activity and how they penetrate a cell remain unclear. Here, we investigate the interfacial structures of positively charged octa-arginine (R8) and its hydrophobically modified analogue, stearyl-octa-arginine (SR8), at negatively charged lipid monolayers using phase-resolved heterodyne-detected vibrational sum-frequency generation (HD-VSFG) spectroscopy. HD-VSFG measurements show that R8 significantly decreases the intensity of the positive OH stretch band of interfacial water, while SR8 changes it to a negative band. This suggests that the hydrophobic stearyl moiety in SR8 promotes higher adsorption efficiency, inducing charge inversion. In the amide I region, R8 exhibits two spectral components at ∼1640 and ∼1680 cm

Identifiers

PMID42317675
PMCPMC13274562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.